Jim Simons Adamas Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	N/A	-763,212 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	N/A	-19,600 Reduced 2.5%	763,212 $3.75 Million
Q2 2021 Aug 13, 2021	SELL	N/A	-29,800 Reduced 3.67%	782,812 $4.13 Million
Q1 2021 May 13, 2021	SELL	N/A	-85,972 Reduced 9.57%	812,612 $3.9 Million
Q4 2020 Feb 10, 2021	BUY	N/A	74,580 Added 9.05%	898,584 $3.89 Million
Q3 2020 Nov 13, 2020	SELL	N/A	-38,250 Reduced 4.44%	824,004 $3.4 Million
Q2 2020 Aug 13, 2020	BUY	N/A	463,874 Added 116.44%	862,254 $2.21 Million
Q1 2020 May 14, 2020	BUY	N/A	105,600 Added 36.07%	398,380 $1.15 Million
Q4 2019 Feb 13, 2020	BUY	N/A	169,145 Added 136.81%	292,780 $1.11 Million
Q3 2019 Nov 13, 2019	BUY	N/A	123,635 New	123,635 $632,000
Q1 2019 May 14, 2019	SELL	N/A	-329,081 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	N/A	329,081 New	329,081 $2.81 Million

About Adamas Pharmaceuticals, Inc.

Ticker ADMS
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,408,100
Market Cap $376M

More about ADMS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.